Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis | Zendy

Andreas Zirlik | Zendy; Shuaib Abdullah | Zendy; Norbert Gerdes | Zendy; Lindsey A. MacFarlane | Zendy; Uwe Schönbeck | Zendy; Amit V. Khera | Zendy; Darren K. McGuire | Zendy; Gloria Lena Vega | Zendy; Scott M. Grundy | Zendy; Peter Libby | Zendy; James A. de Lemos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis

Author(s) -

Andreas Zirlik,

Shuaib Abdullah,

Norbert Gerdes,

Lindsey A. MacFarlane,

Uwe Schönbeck,

Amit V. Khera,

Darren K. McGuire,

Gloria Lena Vega,

Scott M. Grundy,

Peter Libby,

James A. de Lemos

Publication year - 2007

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.107.149484

Subject(s) - metabolic syndrome , asymptomatic , medicine , coronary atherosclerosis , cardiology , subclinical infection , population , coronary artery disease , obesity , environmental health

Although IL-18 promotes atherogenesis in animal studies and predicts cardiovascular risk in humans, it is unknown whether elevated IL-18 levels are associated with coronary atherosclerosis in the general population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research